Immediate Impact
68 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
2024 Standout
Works of Diego Enrico being referenced
Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Diego Enrico | 125 | 58 | 16 | 42 | 28 | 195 | |
| Camille L. Gérard | 186 | 78 | 12 | 79 | 32 | 276 | |
| Khalid Jazieh | 166 | 95 | 27 | 44 | 24 | 263 | |
| Blessie Elizabeth Nelson | 110 | 44 | 40 | 55 | 33 | 207 | |
| Jesus C. Fabregas | 121 | 43 | 34 | 52 | 21 | 228 | |
| Joan Tymon‐Rosario | 96 | 40 | 34 | 37 | 33 | 274 | |
| Sanjeev Deva | 172 | 59 | 28 | 64 | 36 | 240 | |
| Annelieke E.C.A.B. Willemsen | 139 | 100 | 22 | 37 | 25 | 288 | |
| Mario Occhipinti | 159 | 86 | 17 | 50 | 33 | 225 | |
| Maike Trommer | 186 | 85 | 31 | 41 | 32 | 271 | |
| Sanna Iivanainen | 208 | 79 | 16 | 41 | 31 | 257 |
All Works
Login with ORCID to disown or claim papers
Loading papers...